Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
From the Immunodiagnostics Systems website:
"Manufacturing Support for COVID-19
Manufacturing Support
As the world struggles to contain the novel coronavirus (COVID-19) outbreak, it becomes clear that diagnostics test availability is a key constraint. To support our healthcare systems with this challenge, we need to rapidly move production resources into this area.
We at Immunodiagnostic Systems (IDS) want to play a part in the global effort fighting this pandemic. Therefore, we would like to offer our expertise and support in manufacturing ELISA kits for those companies with a COVID-19 diagnostic test that need more production capacity.
What we can provide
IDS is a leading in vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients.
We can offer large scale ELISA plate production, from initial formulation to packaging, labelling and shipment in our ISO 13485 and cGMP qualified facilities in Italy and the United Kingdom.
If you would like to learn more about how we can support your manufacturing efforts or require further information, please contact us on info@idsplc.com.
Let’s work together and make the world a safer place."
https://www.idsplc.com/uncategorised/covid19support/
Immunodiagnostic's current COVID-19 offering is a 'picks & shovels' play.
And remember where that phrase comes from
During the California Gold rush in the 19th century the most reliable way to get rich was reportedly to sell picks and shovels etc to the gold prospectors, rather than actually staking a claim.
"ELISA
... The enzyme-linked immunosorbent assay (ELISA) ... has been used as a diagnostic tool in medicine, plant pathology, and biotechnology, as well as a quality control check in various industries.
In the most simple form of an ELISA, antigens from the sample are attached to a surface. Then, a matching antibody is applied over the surface so it can bind to the antigen. This antibody is linked to an enzyme, and in the final step, a substance containing the enzyme's substrate is added. The subsequent reaction produces a detectable signal, most commonly a color change. ..."
https://en.wikipedia.org/wiki/ELISA
Mass diagnostic testing SHOULD be a game changer in the fight against coronavirus, but there's a global shortage of production capability for this.
IDH is helping to address this, so this SHOULD be a game changer for the company.
Indeed it's a major, lasting business opportunity for IDH, which is clearly moving fast to address this opportunity.
For multiple existing partners, and multiple new partners:
17th Apr 2020 4:35 pm RNS FY20 Trading Update
" ... We are offering our production facilities, and sales network, to several new and existing partners who are in the process of developing COVID-19 test kits. ..."
https://www.lse.co.uk/rns/IDH/fy20-trading-update-ls1laez9k3328x5.html
In contrast to IDH, some of the more speculative POTENTIAL game changers that investors are chasing may never actually work, and their share prices will crash accordingly.
What type would Warren Buffett choose? -
"I would rather be certain of a good result than hopeful of a great one."
http://www.quoteswise.com/warren-buffett-quotes-5.html
That said, IDH could potentially get involved in some 'sexier' COVID-19 business too.
It's spoken in the past about making acquisitions, and has nearly £28M. of cash for both this and new product development.
This could give it the best of both worlds.
And unlike ODX (Omega Diagnostics), there's no risk here of a deeply-discounted placing.
Either way, IDH deserves a re-rating in the current environment, and one should be forthcoming shortly.
For a long time diagnostics companies have been the Cinderella of the health sector: largely lowly-rated and neglected compared to drug developers etc. ... seen as almost a bit 'boring' compared to 'sexier' shares.
But with the coronavirus pandemic, that's now starting to change.
And I believe that we're now moving into a new era where these type stocks could become some of the most sought after on the market.
And as there's not that many of them around, supply and demand dictates that they could become very highly-valued indeed.